The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q33853759

about

Case-based study: from prediabetes to complications--opportunities for prevention Analysis of coding variants in the betacellulin gene in type 2 diabetes and insulin secretion in African American subjects Drug-induced diabetes mellitus HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again 2-Aminoadipic acid is a biomarker for diabetes risk Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.Novel phenotypes of prediabetes?An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass Using Drosophila to discover mechanisms underlying type 2 diabetes Treatment of prediabetes What's next after metformin? focus on sulphonylurea: add-on or combination therapy Alternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic Inflammation Obesity and insulin resistance: an abridged molecular correlation Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus Calcineurin inhibition and new-onset diabetes mellitus after transplantation Changes in beta cell function occur in prediabetes and early disease in the Lepr (db) mouse model of diabetes.Management of critically ill patients with type 2 diabetes: The need for personalised therapy Alogliptin benzoate for management of type 2 diabetes GPR119 agonists for the treatment of type 2 diabetes Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles Perinatal bisphenol A exposure and adult glucose homeostasis: identifying critical windows of exposure Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation Use of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin Secretion The diabetogenic effects of excessive ethanol: reducing beta-cell mass, decreasing phosphatidylinositol 3-kinase activity and GLUT-4 expression in rats Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management Helicobacter pylori infection and diabetes: is it a myth or fact?Population attributable fraction of type 2 diabetes due to physical inactivity in adults: a systematic review Xbp1s in Pomc neurons connects ER stress with energy balance and glucose homeostasis.Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome.The management of type 2 diabetic patients with hypoglycaemic agents Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS).Slow-wave sleep and the risk of type 2 diabetes in humans.The prevention of type 2 diabetes.Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

P2860

Q21144738-1D2EC3A0-7DEC-449A-9D57-5D13FDBAB1CB Q21261450-18AD1F94-2CB8-4BCB-A46E-EBE5399DEED8 Q22306015-C5CEED92-EE0F-4D4C-925A-A4427C40B3D0 Q24299570-ED724D67-4697-48FA-91C9-94D4626EF277 Q24561554-5ED875F0-8DF0-488D-BC07-7BD6CE67CF9D Q24617890-2F659D9A-A44A-4CBF-884B-E840D62B52D2 Q24642412-41BCDE71-DBBB-4369-B5F5-3A48F2B9B91F Q24803901-255D4DD5-C337-48B4-AC18-9D5989EEFAED Q24812084-CDE725E5-B0EA-488B-B4B9-3D6C413F8C8D Q26747128-3A1DD414-923F-44D8-A6D5-3C8C6EEF7A7D Q26749089-4A80D5F7-4906-42BE-8986-AFBEC9459E72 Q26751078-1B485CB9-F0BE-41E6-87A7-0B939099AEA6 Q26783350-FF77EF04-10D2-499F-A6CB-3BFF1D612302 Q26786524-3C207B96-7B25-4633-895C-7180B9E34754 Q26801343-2C599473-FDEE-44E3-95FD-252C8C9FB115 Q26825473-B6AE02B2-646B-42DE-9908-1C9137AC18FD Q26829529-3C33B4B8-C280-4123-96D7-983FEEFD421C Q26865069-4DE30B23-8E08-4CC3-B8AF-87F3E745F39B Q27325700-605CFB95-32DD-4745-B7D8-3E2EF5BBAE8C Q28081465-24808922-2CD6-4DDD-BF17-BAF2034EACDD Q28083933-634E88A9-3C84-4A85-83D2-B14AF52C1540 Q28259606-3C510B3E-FDA7-41D4-8EE7-F0437B113246 Q28484239-3D41DECE-10F0-4282-80FF-F97AE25E3BC2 Q28487927-7E66FA1B-8500-4733-827A-985EDC158DF3 Q28546045-99166217-2655-4C99-A0E1-92E323DA2FA2 Q28551169-2DF0CE85-45AD-43B7-B67F-015D1AB9A6A7 Q28576337-F92D8EFA-5954-4D95-992B-FADE9AE81074 Q30238519-D5611249-50CB-4619-B315-412E4059FF41 Q30361927-E841B3F0-04E6-4261-B0EE-6F01F6F80D7B Q30363110-9F806CC4-1EBD-490C-A8D1-068FCF07BB9F Q30370983-8A8B77E7-E4DD-46EA-9B97-BEDE4D8A2404 Q30413807-DABF62DB-1231-421C-A6DB-8BC63F645E5E Q30417363-E84F902C-8BE4-4CA0-845A-EE583C45416C Q30423466-6AB0F2A6-B3B0-4779-B5BB-7861BB505048 Q30435651-BAFF3AAD-6376-47F5-B719-921DF2D21C66 Q30481284-9BF0112F-9B96-4FA3-B0B1-5AC1C2C6238D Q30484253-AD4C1B78-44C2-4119-95CC-E15636F28D55 Q30489774-982F9966-2A68-4A9D-A380-E17C027CC7AB Q30533186-0DD9FA4D-D367-4E02-8940-837A4A6989DB Q30597265-2920A185-F1F6-4B21-8E36-4C36471031F9

P2860

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q33853759

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

The natural history of insulin ...... s of type 2 diabetes mellitus.

@ast

The natural history of insulin ...... s of type 2 diabetes mellitus.

@en

type

label

The natural history of insulin ...... s of type 2 diabetes mellitus.

@ast

The natural history of insulin ...... s of type 2 diabetes mellitus.

@en

prefLabel

The natural history of insulin ...... s of type 2 diabetes mellitus.

@ast

The natural history of insulin ...... s of type 2 diabetes mellitus.

@en

P1433

Q33853759-F1E32308-893D-4F2B-98AE-F95D65255024

P1476

Q33853759-582C74D6-30F8-4FBC-ADFD-C67B007C89E3

P2093

Q33853759-15337197-ECA3-459A-9863-3846443570E1

Q33853759-3CBEB7E6-FEBB-4894-BD12-42AFFF002927

Q33853759-E299D45B-8A68-4F9A-8A66-FCEAB2CB8E20

Q33853759-F1C6E561-7CFE-411D-B4BB-7683532FAA49

P2860

Q33853759-02259724-5DC8-4565-927B-7962406FA567

Q33853759-04BB0CFA-9435-4D2C-9BC8-0D577D3EA7D8

Q33853759-17735BE0-EA15-4B7E-911C-397CF07C7FD3

Q33853759-179725CC-2482-4329-B3B7-09E089ED523D

Q33853759-1B96F514-3200-438E-9D88-D28C5F57C809

Q33853759-28FB4C01-43FE-4996-B03D-5F3C9AC1A360

Q33853759-2AAC579E-31A0-41DF-8813-937AF5E9E562

Q33853759-2B5DBFFE-4955-484B-A50D-C40AEBC26825

Q33853759-2D3710B0-52F6-43A7-A1AB-EFF309456E6D

Q33853759-3082888C-F0CB-4360-92C5-BF703E561AB4

P304

Q33853759-898AD607-940D-49A0-A984-DADF795134C1

P31

Q33853759-BD447CF6-E102-485A-BD43-23C28E532E09

P356

Q33853759-C05B8ED3-22A6-4104-9A4E-BB022742944C

P407

Q33853759-9D70FBDA-0EC4-4861-B54B-436FD21F43B8

P433

Q33853759-8D5F1C0B-D771-4168-9634-3B03B5CAD313

P478

Q33853759-9FEC5352-2544-4AD0-B686-A72BA27475DA

P577

Q33853759-DA0B3DAF-72DD-4606-95DC-15A79E6F06F0

P698

Q33853759-E8831BB3-1D41-4740-B7FB-A8C2EA8B6AF8

P921

Q33853759-742AE4F8-925D-4F2D-9420-100287784AAA

Q33853759-B80A4C81-5B98-4EA0-9313-7BA086D3A762

Q33853759-F72635CD-121B-44E6-A40E-3362E6751A75

P932

Q33853759-4BA378AC-D401-48FF-9C06-77FE8D50E04D

P356

P1433

Journal of Clinical Investigation

P1476

The natural history of insulin ...... s of type 2 diabetes mellitus.

@en

P2093

C Bogardus

http://www.w3.org/2001/XMLSchema#string

C Weyer

http://www.w3.org/2001/XMLSchema#string

D M Mott

http://www.w3.org/2001/XMLSchema#string

R E Pratley

http://www.w3.org/2001/XMLSchema#string

P2860

Immunoassay of endogenous plasma insulin in man

Banting lecture 1988. Role of insulin resistance in human disease

Natural history of impaired glucose tolerance: follow-up at Joslin Clinic.

Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians.

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

Postabsorptive respiratory quotient and insulin-stimulated glucose storage rate in nondiabetic pima indians are related To glycogen synthase fractional activity in cultured myoblasts.

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis.

Natural history of beta-cell dysfunction in NIDDM.

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach.

P304

787-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI7231

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10491414

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

408438

http://www.w3.org/2001/XMLSchema#string